Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study (vol 75, pg 2570, 2020)

被引:0
|
作者
Boccara, F.
Kumar, P. N.
Caramelli, B.
Calmy, A.
Lopez, J. A. G.
Bray, S.
Cyrille, M.
Rosenson, R. S.
机构
关键词
D O I
10.1016/j.jacc.2020.06.056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:762 / 765
页数:5
相关论文
共 50 条
  • [1] Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study
    Boccara, Franck
    Kumar, Princy N.
    Caramelli, Bruno
    Calmy, Alexandra
    Lopez, J. Antonio G.
    Bray, Sarah
    Cyrille, Marcoli
    Rosenson, Robert S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (20) : 2570 - 2584
  • [2] EVOLOCUMAB USE IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS AND DYSLIPIDEMIA: PRIMARY RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (BEIJERINCK)
    Boccara, Franck
    Kumar, Princy
    Caramelli, Bruno
    Calmy, Alexandra
    Lopez, J. Antonio G.
    Bray, Sarah
    Cyrille, Marcoli
    Rosenson, Robert S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1832 - 1832
  • [3] Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
    Wongprikorn, Asita
    Sukasem, Chonlaphat
    Puangpetch, Apichaya
    Numthavej, Pawin
    Thakkinstian, Ammarin
    Kiertiburanakul, Sasisopin
    PLOS ONE, 2016, 11 (06):
  • [4] Use of probiotics in HIV-infected children: A randomized double-blind controlled study
    Trois, Livia
    Cardoso, Edmundo Machado
    Miura, Ernani
    JOURNAL OF TROPICAL PEDIATRICS, 2008, 54 (01) : 19 - 24
  • [5] Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511)
    Saag, MS
    Tebas, P
    Sension, M
    Conant, M
    Myers, R
    Chapman, SK
    Anderson, R
    Clendeninn, N
    AIDS, 2001, 15 (15) : 1971 - 1978
  • [6] A Randomized, Double-Blind, Placebo-Controlled Study of Benfluorex in HIV-Infected Patients with Insulin Resistance or Impaired Glucose Tolerance
    Poizot-Martin, I.
    Drogoul-Vey, M. P.
    Di Stefano, D.
    Jouve, E.
    Fabre, G.
    Saout, A.
    Gastaut, J. A.
    HIV CLINICAL TRIALS, 2009, 10 (01): : 33 - 40
  • [7] A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial
    Montaner, JSG
    Reiss, P
    Cooper, D
    Vella, S
    Harris, M
    Conway, B
    Wainberg, MA
    Smith, D
    Robinson, P
    Hall, D
    Myers, M
    Lange, JMA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12): : 930 - 937
  • [8] Iron Supplementation in HIV-Infected Malawian Children With Anemia: A Double-Blind, Randomized, Controlled Trial
    Esan, Michael O.
    van Hensbroek, Michael Boele
    Nkhoma, Ernest
    Musicha, Crispin
    White, Sarah A.
    ter Kuile, Feiko O.
    Phiri, Kamija S.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (11) : 1626 - 1634
  • [9] A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency
    Chetchotisakd, P
    Sungkanuparph, S
    Thinkhamrop, B
    Mootsikapun, P
    Boonyaprawit, P
    HIV MEDICINE, 2004, 5 (03) : 140 - 143
  • [10] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF THYMOSTIMULIN IN SYMPTOMATIC HIV-INFECTED PATIENTS
    BEALL, G
    KRUGER, S
    MORALES, F
    IMAGAWA, D
    GOLDSMITH, JA
    FISHER, D
    STEINBERG, J
    PHAIR, J
    WHALING, S
    BITRAN, J
    AIDS, 1990, 4 (07) : 679 - 681